Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Comprehensive analysis of the associations between clinical factors and outcomes by machine learning, using post marketing surveillance data of cabazitaxel in patients with castration-resistant prostate cancer

Fig. 1

Kaplan–Meier analysis of OS for patient subgroups. a: liver metastasis; b: lung metastasis; c: ECOG PS; d: neutropenia; e: febrile neutropenia; f: number of cycles of cabazitaxel administration. CI confidence interval; ECOG PS Eastern Cooperative Oncology Group performance status; HR hazard ratio; OS overall survival

Back to article page